Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) FCF Margin (2016 - 2025)

Marimed (MRMD) has disclosed FCF Margin for 13 consecutive years, with 8.15% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 1193.0% to 8.15% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.81% through Dec 2025, up 290.0% year-over-year, with the annual reading at 4.08% for FY2025, 737.0% up from the prior year.
  • FCF Margin for Q4 2025 was 8.15% at Marimed, up from 3.38% in the prior quarter.
  • The five-year high for FCF Margin was 31.85% in Q3 2021, with the low at 29.03% in Q4 2022.
  • Average FCF Margin over 5 years is 4.27%, with a median of 4.14% recorded in 2024.
  • The sharpest move saw FCF Margin crashed -5280bps in 2022, then skyrocketed 4880bps in 2023.
  • Over 5 years, FCF Margin stood at 14.12% in 2021, then tumbled by -306bps to 29.03% in 2022, then soared by 168bps to 19.77% in 2023, then plummeted by -119bps to 3.78% in 2024, then surged by 316bps to 8.15% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 8.15%, 3.38%, and 3.29% for Q4 2025, Q3 2025, and Q2 2025 respectively.